Rashid Bux, a Director, acquired 1,040,000 Common Shares on an indirect ownership basis for registered holder BUX INVESTMENT LTD at a price of $0.250 through a prospectus or prospectus exempt offering on May 4th, 2022. The insider also acquired 1,040,000 Warrants on an indirect ownership basis for registered holder BUX INVESTMENT LTD with an exercise price of $0.450 for two years. This represents a $260,000 investment into the company's shares and an account share holdings change of 43.8%.
Biomark Diagnostics is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.
No Comments